Skip to main content
Top
Published in: Diabetologia 6/2014

01-06-2014 | Article

Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity

Authors: Katarzyna Linder, Franziska Schleger, Caroline Ketterer, Louise Fritsche, Isabelle Kiefer-Schmidt, Anita Hennige, Hans-Ulrich Häring, Hubert Preissl, Andreas Fritsche

Published in: Diabetologia | Issue 6/2014

Login to get access

Abstract

Aims/hypothesis

Fetal programming plays an important role in the pathogenesis of type 2 diabetes. The aim of the present study was to investigate whether maternal metabolic changes during OGTT influence fetal brain activity.

Methods

Thirteen healthy pregnant women underwent an OGTT (75 g). Insulin sensitivity was determined by glucose and insulin measurements at 0, 60 and 120 min. At each time point, fetal auditory evoked fields were recorded with a fetal magnetoencephalographic device and response latencies were determined.

Results

Maternal insulin increased from a fasting level of 67 ± 25 pmol/l (mean ± SD) to 918 ± 492 pmol/l 60 min after glucose ingestion and glucose levels increased from 4.4 ± 0.3 to 7.4 ± 1.1 mmol/l. Over the same time period, fetal response latencies decreased from 297 ± 99 to 235 ± 84 ms (p = 0.01) and then remained stable until 120 min (235 ± 84 vs 251 ± 91 ms, p = 0.39). There was a negative correlation between maternal insulin sensitivity and fetal response latencies 60 min after glucose ingestion (r = 0.68, p = 0.02). After a median split of the group based on maternal insulin sensitivity, fetuses of insulin-resistant mothers showed a slower response to auditory stimuli (283 ± 79 ms) than those of insulin-sensitive mothers (178 ± 46 ms, p = 0.03).

Conclusions/interpretation

Lower maternal insulin sensitivity is associated with slower fetal brain responses. These findings provide the first evidence of a direct effect of maternal metabolism on fetal brain activity and suggest that central insulin resistance may be programmed during fetal development.
Literature
1.
go back to reference Hallschmid M, Schultes B (2009) Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia 52:2264–2269PubMedCrossRef Hallschmid M, Schultes B (2009) Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia 52:2264–2269PubMedCrossRef
3.
go back to reference Porte D, Baskin DG, Schwartz MW (2005) Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264–1276PubMedCrossRef Porte D, Baskin DG, Schwartz MW (2005) Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264–1276PubMedCrossRef
4.
go back to reference Benedict C, Brede S, Schiöth HB et al (2011) Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60:114–118PubMedCentralPubMedCrossRef Benedict C, Brede S, Schiöth HB et al (2011) Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60:114–118PubMedCentralPubMedCrossRef
5.
go back to reference Heni M, Kullmann S, Ketterer C et al (2012) Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 55:1773–1782PubMedCrossRef Heni M, Kullmann S, Ketterer C et al (2012) Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 55:1773–1782PubMedCrossRef
6.
go back to reference Tschritter O, Preissl H, Hennige AM et al (2012) High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 55:175–182PubMedCrossRef Tschritter O, Preissl H, Hennige AM et al (2012) High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 55:175–182PubMedCrossRef
7.
go back to reference Tschritter O, Preissl H, Hennige AM et al (2006) The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A 103:12103–12108PubMedCentralPubMedCrossRef Tschritter O, Preissl H, Hennige AM et al (2006) The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A 103:12103–12108PubMedCentralPubMedCrossRef
8.
go back to reference Tschritter O, Preissl H, Hennige AM et al (2009) The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified fatty acids. J Clin Endocrinol Metab 94:4600–4607PubMedCrossRef Tschritter O, Preissl H, Hennige AM et al (2009) The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified fatty acids. J Clin Endocrinol Metab 94:4600–4607PubMedCrossRef
9.
go back to reference Nolan CJ, Damm P, Prentki M (2009) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169–181CrossRef Nolan CJ, Damm P, Prentki M (2009) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169–181CrossRef
10.
go back to reference Plagemann A (2008) A matter of insulin: developmental programming of body weight regulation. J Matern Fetal Neonatal Med 21:143–148PubMedCrossRef Plagemann A (2008) A matter of insulin: developmental programming of body weight regulation. J Matern Fetal Neonatal Med 21:143–148PubMedCrossRef
11.
go back to reference Barker DJ, Osmond C, Simmonds SJ, Wield GA (1993) The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306:422–426PubMedCentralPubMedCrossRef Barker DJ, Osmond C, Simmonds SJ, Wield GA (1993) The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life. BMJ 306:422–426PubMedCentralPubMedCrossRef
13.
go back to reference Rao S, Yajnik CS, Kanade A et al (2001) Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 131:1217–1224PubMed Rao S, Yajnik CS, Kanade A et al (2001) Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 131:1217–1224PubMed
14.
go back to reference Yajnik CS (2004) Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 134:205–210PubMed Yajnik CS (2004) Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 134:205–210PubMed
15.
go back to reference Schaefer-Graf UM, Pawliczak J, Passow D et al (2005) Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 28:1745–1750PubMedCrossRef Schaefer-Graf UM, Pawliczak J, Passow D et al (2005) Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes. Diabetes Care 28:1745–1750PubMedCrossRef
16.
go back to reference Sobngwi E, Boudou P, Mauvais-Jarvis F et al (2003) Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361:1861–1865PubMedCrossRef Sobngwi E, Boudou P, Mauvais-Jarvis F et al (2003) Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361:1861–1865PubMedCrossRef
17.
18.
go back to reference Preissl H, Lowery CL, Eswaran H (2004) Fetal magnetoencephalography: current progress and trends. Exp Neurol 190(Suppl 1):28–36CrossRef Preissl H, Lowery CL, Eswaran H (2004) Fetal magnetoencephalography: current progress and trends. Exp Neurol 190(Suppl 1):28–36CrossRef
19.
go back to reference Eswaran H, Wilson JD, Preissl H et al (2002) Magnetoencephalographic recordings of visual evoked brain activity in the human fetus. Lancet 360:779–780PubMedCrossRef Eswaran H, Wilson JD, Preissl H et al (2002) Magnetoencephalographic recordings of visual evoked brain activity in the human fetus. Lancet 360:779–780PubMedCrossRef
20.
go back to reference Eswaran H, Preissl H, Wilson JD et al (2002) Short-term serial magnetoencephalography recordings of fetal auditory evoked responses. Neurosci Lett 331:128–132PubMedCrossRef Eswaran H, Preissl H, Wilson JD et al (2002) Short-term serial magnetoencephalography recordings of fetal auditory evoked responses. Neurosci Lett 331:128–132PubMedCrossRef
21.
go back to reference Schneider U, Schleussner E, Haueisen J, Nowak H, Seewald HJ (2001) Signal analysis of auditory evoked cortical fields in fetal magnetoencephalography. Brain Topogr 14:69–80PubMedCrossRef Schneider U, Schleussner E, Haueisen J, Nowak H, Seewald HJ (2001) Signal analysis of auditory evoked cortical fields in fetal magnetoencephalography. Brain Topogr 14:69–80PubMedCrossRef
22.
go back to reference Holst M, Eswaran H, Lowery C, Murphy P, Norton J, Preissl H (2005) Development of auditory evoked fields in human fetuses and newborns: a longitudinal MEG study. Clin Neurophysiol 116:1949–1955PubMedCrossRef Holst M, Eswaran H, Lowery C, Murphy P, Norton J, Preissl H (2005) Development of auditory evoked fields in human fetuses and newborns: a longitudinal MEG study. Clin Neurophysiol 116:1949–1955PubMedCrossRef
23.
go back to reference Kiefer ID, Siegel ER, Preissl H et al (2008) Delayed maturation of auditory evoked responses in growth-restricted fetuses revealed by magnetoencephalographic recordings. Am J Obstet Gynecol 199:503.e1–503.e7CrossRef Kiefer ID, Siegel ER, Preissl H et al (2008) Delayed maturation of auditory evoked responses in growth-restricted fetuses revealed by magnetoencephalographic recordings. Am J Obstet Gynecol 199:503.e1–503.e7CrossRef
24.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
25.
go back to reference Stumvoll M, van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796–797PubMedCrossRef Stumvoll M, van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24:796–797PubMedCrossRef
26.
go back to reference Querleu D, Renard X, Versyp F, Paris-Delrue L, Crèpin G (1988) Fetal hearing. Eur J Obstet Gynecol Reprod Biol 29:191–212CrossRef Querleu D, Renard X, Versyp F, Paris-Delrue L, Crèpin G (1988) Fetal hearing. Eur J Obstet Gynecol Reprod Biol 29:191–212CrossRef
27.
go back to reference McCubbin J, Robinson SE, Cropp R et al (2006) Optimal reduction of MCG in fetal MEG recordings. IEEE Trans Biomed Eng 53:1720–1724PubMedCrossRef McCubbin J, Robinson SE, Cropp R et al (2006) Optimal reduction of MCG in fetal MEG recordings. IEEE Trans Biomed Eng 53:1720–1724PubMedCrossRef
28.
go back to reference Vrba J, Robinson SE, Mccubbin J et al (2004) Fetal MEG redistribution by projection operators. IEEE Trans Biomed Eng 51:1207–1218PubMedCrossRef Vrba J, Robinson SE, Mccubbin J et al (2004) Fetal MEG redistribution by projection operators. IEEE Trans Biomed Eng 51:1207–1218PubMedCrossRef
29.
go back to reference Vrba J, Robinson SE, McCubbin J et al (2004) Human fetal brain imaging by magnetoencephalography: verification of fetal brain signals by comparison with fetal brain models. NeuroImage 21:1009–1020PubMedCrossRef Vrba J, Robinson SE, McCubbin J et al (2004) Human fetal brain imaging by magnetoencephalography: verification of fetal brain signals by comparison with fetal brain models. NeuroImage 21:1009–1020PubMedCrossRef
30.
go back to reference Pedersen J (1967) The pregnant diabetic and her newborn: problems and management. William & Wilkins, Baltimore Pedersen J (1967) The pregnant diabetic and her newborn: problems and management. William & Wilkins, Baltimore
31.
go back to reference Catalano PM, Hauguel-De Mouzon S (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204:479–487PubMedCentralPubMedCrossRef Catalano PM, Hauguel-De Mouzon S (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204:479–487PubMedCentralPubMedCrossRef
32.
go back to reference Silverman BL, Metzger BE, Cho NH, Loeb CA (1995) Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 18:611–617PubMedCrossRef Silverman BL, Metzger BE, Cho NH, Loeb CA (1995) Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care 18:611–617PubMedCrossRef
Metadata
Title
Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity
Authors
Katarzyna Linder
Franziska Schleger
Caroline Ketterer
Louise Fritsche
Isabelle Kiefer-Schmidt
Anita Hennige
Hans-Ulrich Häring
Hubert Preissl
Andreas Fritsche
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3217-9

Other articles of this Issue 6/2014

Diabetologia 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.